Oricell Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Oricell Therapeutics?

Oricell Therapeutics has 26 investors including Talon Capital And Lucion.

Q: How much funding has Oricell Therapeutics raised to date?

Oricell Therapeutics has raised obfuscated.

Overview

Oricell Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Oricell Therapeutics

CB Rank

9848

OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy.

Founded

obfuscation

Private

Venture - Series Unknown

Shanghai, Shanghai, China

51-100

www.oricell.com/en/

Health Care

Pharmaceutical

Product Research

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series C

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Details

Legal Name

OriCell Biotechnology (Shanghai) Co., Ltd.

Also Known As

Yuanneng Medicine, Yuanqi Bio, OriCell Medical Technology, 原启生物

Operating Status

Active

Company Type

For Profit

About the Company

OriCell Therapeutics develop drugs with good efficacy and affordable prices to satisfy the globally unmet clinical needs through innovations and strives to become the world-leading developer of novel drugs for tumor immunotherapy.

Phone Number

8621-68868119

Predictions & Insights

Growth Insight

See this Growth Insight

Oricell Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

OriCAR-017

A CAR-T cell therapy targeting GPRC5D for treating relapsed or refractory multiple myeloma.

Ori-C101

A CAR-T cell therapy targeting GPC3 for treating advanced hepatocellular carcinoma.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Oricell Therapeutics	8	obfuscated obfuscation	Beijing Medical and Health Industry Investment Fund, Qiming Venture Partners, Vivo Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oricell Therapeutics	8	obfuscated obfuscation	Beijing Medical and Health Industry Investment Fund, Qiming Venture Partners, Vivo Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oricell Therapeutics	8	obfuscated obfuscation	Beijing Medical and Health Industry Investment Fund, Qiming Venture Partners, Vivo Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oricell Therapeutics	8	obfuscated obfuscation	Beijing Medical and Health Industry Investment Fund, Qiming Venture Partners, Vivo Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oricell Therapeutics	8	obfuscated obfuscation	Beijing Medical and Health Industry Investment Fund, Qiming Venture Partners, Vivo Capital	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Oricell Therapeutics	8	obfuscated obfuscation	Beijing Medical and Health Industry Investment Fund, Qiming Venture Partners, Vivo Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oricell Therapeutics	8	obfuscated obfuscation	Beijing Medical and Health Industry Investment Fund, Qiming Venture Partners, Vivo Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oricell Therapeutics	8	obfuscated obfuscation	Beijing Medical and Health Industry Investment Fund, Qiming Venture Partners, Vivo Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oricell Therapeutics	8	obfuscated obfuscation	Beijing Medical and Health Industry Investment Fund, Qiming Venture Partners, Vivo Capital	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Oricell Therapeutics	8	obfuscated obfuscation	Beijing Medical and Health Industry Investment Fund, Qiming Venture Partners, Vivo Capital	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Talon Capital	—	Venture Round - Oricell Therapeutics	—
Talon Capital	—	Venture Round - Oricell Therapeutics	—
Talon Capital	—	Venture Round - Oricell Therapeutics	—
Talon Capital	—	Venture Round - Oricell Therapeutics	—
Talon Capital	—	Venture Round - Oricell Therapeutics	—